Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Soligenix, Inc.

NASDAQ: SNGX · Life Sciences · 2 alerts · CIK 812796

Share price
$0.2882Close, Nov 16
Market cap
$6.73M
Shares outstanding
23.37MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Soligenix, Inc. filings on SEC EDGAR ↗

4:07 PM ET 10-Q
Financial Results

Soligenix Q3 2026 Results: Net Loss of $1.12M, Loss Narrows

Soligenix, Inc. reported a net loss of $5.93 million for the nine months ended September 30, 2026, an improvement from the $8.18 million loss in the prior year period. The company significantly increased its cash position to $9.02 million through the issuance of common stock via an At Market Issuance Sales Agreement, while operating expenses decreased primarily due to lower research and development spending.

Key figure
Net loss $1.12M
4:31 PM ET 8-K
Shareholder Meeting

Soligenix Shareholder Meeting

Soligenix held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and approved several key proposals. Major outcomes included the ratification of an increase in authorized common shares from 75 million to 125 million and the approval of a discretionary reverse stock split at a ratio between 1-for-2 and 1-for-20.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.